Physician profile
Dev D Jaiswal
NPI 1831639152
$11,810.18
in general payments reported to CMS, 2019-2025
34 companies · $664 in 2025
The $664 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $1,070 · 2021: $2,517 · 2022: $1,936 · 2023: $2,308 · 2024: $2,812 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,414 · Travel and Lodging: $1,330 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,413.73 |
| Travel and Lodging | $1,329.93 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,247.37 | 2019-2025 | Gallant, Aveir, Confirm Rx |
| Boston Scientific Corporation | $3,004.13 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Rotablator Rotational Atherectomy System Console Kit, Ekosonic |
| Philips North America LLC | $1,707.67 | 2021-2024 | (Bq9) Coronary Ivus, (6554) Peripheral Vascular Undivided, (Bh4) Igt Devices Undivided |
| Penumbra, INC. | $417.83 | 2024-2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $283.20 | 2024-2025 | |
| Edwards Lifesciences Corporation | $262.24 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $257.63 | 2024-2025 | Impella |
| Chiesi USA, INC. | $255.49 | 2020-2023 | Kengreal |
| Shockwave Medical, INC | $133.48 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $124.99 | 2019 | |
| Amgen INC. | $118.25 | 2021-2024 | Repatha |
| Cvrx, INC. | $100.23 | 2024-2025 | Barostim Neo System |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.13 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $77.54 | 2019-2024 | Wainua |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $73.77 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.74 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $69.50 | 2019-2022 | |
| Tetraphase Pharmaceuticals, INC. | $55.63 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $44.45 | 2024-2025 | Eliquis, Camzyos |
| Atricure, INC. | $43.18 | 2020 | |
| Stryker Corporation | $39.69 | 2025 | Artix Mt |
| Viiv Healthcare Company | $33.55 | 2019-2020 | |
| Ethicon US, LLC | $25.76 | 2025 | Stratafix, Dermabond, Vistaseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.77 | 2025 | Lifevest |
| Analog Devices INC. | $20.36 | 2025 | Sensinel Cpm Wearable |
| Esperion Therapeutics, INC. | $19.99 | 2021 | |
| Pfizer INC. | $19.25 | 2021 | |
| Medtronic, INC. | $18.36 | 2021 | |
| Gilead Sciences, INC. | $18.36 | 2019 | |
| Pylant Medical | $17.73 | 2022 | |
| La Jolla Pharmaceutical Company | $16.40 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.71 | 2024 | |
| Paratek Pharmaceuticals, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dev Jaiswal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.